Trials / Recruiting
RecruitingNCT06302049
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial.
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Sadat City University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to test the implication of esomeprazole as a possible potential therapy for patients with NASH through evaluating its effect on ultrasound and fibrosis risk scores, serum levels of liver fibrosis biomarkers (fibronectin 1), insulin resistance, metabolic and inflammatory parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | esomeprazole 20 mg once daily |
| DRUG | Placebo | Placebo once daily |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-05-01
- Completion
- 2026-05-01
- First posted
- 2024-03-08
- Last updated
- 2024-05-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06302049. Inclusion in this directory is not an endorsement.